AVBC vs PKBK
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health scores paint a concerning picture, with a Piotroski F-Score of just 1/9 indicating severe financial weakness. Despite strong year-over-year revenue growth of 28%, the company is unprofitable with negative profit and operating margins, undermining its financial stability. Valuation metrics like a Price/Book of 0.93 suggest the market is pricing in limited confidence, while the technical trend score of 10/100 reflects strong bearish momentum. The absence of Altman Z-Score data is a red flag, but the extremely low Piotroski score alone warrants significant caution.
PKBK presents a compelling value opportunity, trading significantly below its Graham Number ($44.50) and Intrinsic Value ($93.22). While the Piotroski F-Score of 4/9 indicates stable but not exceptional financial health, the company's growth metrics are outstanding, with YoY earnings growth of 53.30% and a very low PEG ratio of 0.43. Despite strong fundamentals and a sustainable dividend payout, the stock faces short-term headwinds from a bearish technical trend and significant insider selling.
Compare Another Pair
Related Comparisons
AVBC vs PKBK: Head-to-Head Comparison
This page compares Avidia Bancorp, Inc. (AVBC) and Parke Bancorp, Inc. (PKBK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.